Dr. Jennings received her medical degree from Oregon Health & Science University, her training in neurology from Boston University and completed a movement disorders fellowship at Columbia Presbyterian Medical Center in New York. She was a teaching faculty member in the department of neurology at Yale University prior to her current position as clinical research director at the Institute for Neurodegenerative Disorders in New Haven, Connecticut. Dr. Jennings has been an active member of the Parkinson’s and most research communities. Over the past 14 years, she has served as investigator on over 30 clinical trials aimed at the development of improvements in the diagnosis and treatment of Parkinson’s disease. Dr. Jennings' specific research interests include the development of accurate diagnostic tests to detect changes in the brain that may occur even prior to symptoms in neurologic conditions. She is currently involved in several studies aimed at the development of medications that may modify the rate of progression of Parkinson’s disease In addition, she has designed studies that focus on developing a better understanding of factors that may play a role in identifying individuals at increased risk for Parkinson’s disease.